Xilio Therapeutics, Inc. (XLO)
8.48
+0.07
(+0.83%)
USD |
NASDAQ |
Apr 01, 16:00
8.50
+0.02
(+0.24%)
After-Hours: 20:00
Xilio Therapeutics Shareholders Equity (Quarterly) : 35.27M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.54B |
| Merck & Co., Inc. | 52.61B |
| Pfizer Inc. | 86.48B |
| Verastem, Inc. | 57.20M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 156.69M |
| Total Liabilities (Quarterly) | 121.42M |
| Debt to Equity Ratio | 0.1971 |
| Current Ratio | 2.577 |
| Net Debt Paydown Yield | 0.05% |